This inhibitor of JNK has been studied in several models in vivo (Borsello et al., 2003; Wiegler et al., 2008) and its neuroprotective properties have been demonstrated in animal models of cerebral ischemia and stroke (Deloche et al., 2014). Here, MAPK8 is linked to stroke disorder.